These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11799193)
1. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. Urban S; Gripon P J Virol; 2002 Feb; 76(4):1986-90. PubMed ID: 11799193 [TBL] [Abstract][Full Text] [Related]
2. Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes. Dallmeier K; Schultz U; Nassal M PLoS Pathog; 2008 Dec; 4(12):e1000230. PubMed ID: 19057662 [TBL] [Abstract][Full Text] [Related]
3. Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection. Li J; Tong S; Lee HB; Perdigoto AL; Spangenberg HC; Wands JR J Virol; 2004 Feb; 78(4):1873-81. PubMed ID: 14747552 [TBL] [Abstract][Full Text] [Related]
4. Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180. Urban S; Breiner KM; Fehler F; Klingmüller U; Schaller H J Virol; 1998 Oct; 72(10):8089-97. PubMed ID: 9733849 [TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection. Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204 [TBL] [Abstract][Full Text] [Related]
6. [Inhibition of binding peptides on replication of duck hepatitis B virus]. Jia HY; Chen Z; Zhou LF; Chen F; Zhu HH; Liu JH; Xu XY Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 34(2):116-20. PubMed ID: 15812883 [TBL] [Abstract][Full Text] [Related]
7. Viral and cellular determinants involved in hepadnaviral entry. Glebe D; Urban S World J Gastroenterol; 2007 Jan; 13(1):22-38. PubMed ID: 17206752 [TBL] [Abstract][Full Text] [Related]
8. Cloning, expression and purification of duck hepatitis B virus (DHBV) core protein and its use in the development of an indirect ELISA for serologic detection of DHBV infection. Liu Q; Jia R; Wang M; Huang J; Zhu D; Chen S; Yin Z; Wang Y; Chen X; Cheng A Arch Virol; 2014 May; 159(5):897-904. PubMed ID: 24158348 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Miller DS; Kotlarski I; Jilbert AR Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364 [TBL] [Abstract][Full Text] [Related]
10. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150 [TBL] [Abstract][Full Text] [Related]
11. Alternative methods for validation of cell culture infection with duck hepatitis B virus. Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155 [TBL] [Abstract][Full Text] [Related]
12. Primary Duck Hepatocyte Culture and Duck Hepatitis B Virus Infection Model. Li J; Tong S Methods Mol Biol; 2024; 2837():11-22. PubMed ID: 39044071 [TBL] [Abstract][Full Text] [Related]
13. Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection. Tong S; Li J; Wands JR J Virol; 1995 Nov; 69(11):7106-12. PubMed ID: 7474130 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates. Maenz C; Loscher C; Iwanski A; Bruns M J Gen Virol; 2008 Dec; 89(Pt 12):3016-3026. PubMed ID: 19008388 [TBL] [Abstract][Full Text] [Related]
15. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection. Miller DS; Halpern M; Kotlarski I; Jilbert AR Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347 [TBL] [Abstract][Full Text] [Related]
16. A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus. Meier P; Scougall CA; Will H; Burrell CJ; Jilbert AR Virology; 2003 Dec; 317(2):291-8. PubMed ID: 14698667 [TBL] [Abstract][Full Text] [Related]
17. [Research on the gene structure of duck hepatitis B virus and its encoding proteins]. Liu Q; Jia RY Bing Du Xue Bao; 2012 Nov; 28(6):681-8. PubMed ID: 23367570 [TBL] [Abstract][Full Text] [Related]
18. [The effect of ribozyme RzDS on duck hepatitis B virus]. Li H; Chen W; Xu W Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):118-21. PubMed ID: 12515186 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. Pugh JC; Di Q; Mason WS; Simmons H J Virol; 1995 Aug; 69(8):4814-22. PubMed ID: 7609048 [TBL] [Abstract][Full Text] [Related]
20. [Antisense oligodeoxynucleotide targeted at the pre-s region of DHBV could inhibit virus replication in vivo]. He L; Wu X; Chen C Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):1-4. PubMed ID: 12515159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]